BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Staging
28 results:

  • 1. Leveraging a cuproptosis-based signature to predict the prognosis and drug sensitivity of cutaneous melanoma.
    Liu D; Yang F; Zhang T; Mao R
    J Transl Med; 2023 Jan; 21(1):57. PubMed ID: 36717900
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Metastatic malignant melanoma of the breast: report of a case and review of the literature.
    Mastoraki A; Gkiala A; Theodoroleas G; Mouchtouri E; Strimpakos A; Papagiannopoulou D; Schizas D
    Folia Med (Plovdiv); 2022 Apr; 64(2):354-358. PubMed ID: 35851793
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022.
    Garbe C; Amaral T; Peris K; Hauschild A; Arenberger P; Basset-Seguin N; Bastholt L; Bataille V; Del Marmol V; Dréno B; Fargnoli MC; Forsea AM; Grob JJ; Hoeller C; Kaufmann R; Kelleners-Smeets N; Lallas A; Lebbé C; Lytvynenko B; Malvehy J; Moreno-Ramirez D; Nathan P; Pellacani G; Saiag P; Stratigos AJ; Van Akkooi ACJ; Vieira R; Zalaudek I; Lorigan P;
    Eur J Cancer; 2022 Jul; 170():256-284. PubMed ID: 35623961
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021.
    Ascierto PA; Warner AB; Blank C; Caracò C; Demaria S; Gershenwald JE; Khushalani NI; Long GV; Luke JJ; Mehnert JM; Robert C; Rutkowski P; Tawbi HA; Osman I; Puzanov I
    J Transl Med; 2022 May; 20(1):200. PubMed ID: 35538491
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Generalized morphoea in the setting of combined immune checkpoint inhibitor therapy for metastatic melanoma: A case report.
    Langan EA; Budner K; Zillikens D; Terheyden P
    Medicine (Baltimore); 2021 Apr; 100(16):e25513. PubMed ID: 33879687
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The "Great Debate" at Melanoma Bridge 2020: December, 5th, 2020.
    Ascierto PA; Atkins MB; Eggermont AM; Gershenwald JE; Grob JJ; Hamid O; Sondak VK; Sosman JA; Tawbi HA; Weber JS; Caracò C; Osman I; Puzanov I
    J Transl Med; 2021 Apr; 19(1):142. PubMed ID: 33827575
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Decreased Expression of CPEB3 Predicts a Poor Prognosis in Patients with Melanoma: A Study Based on TCGA Data.
    Zhang X; Liang Y
    Biomed Res Int; 2021; 2021():8197936. PubMed ID: 33506034
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Olfactory Neuroblastoma.
    Veyrat M; Vérillaud B; Fiaux-Camous D; Froelich S; Bresson D; Nicolai P; Herman P
    Adv Otorhinolaryngol; 2020; 84():154-167. PubMed ID: 32731231
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Great Debate at "Melanoma Bridge", Naples, December 7th, 2019.
    Ascierto PA; Agarwala SS; Eggermont A; Gershenwald JE; Grob JJ; Hamid O; Michielin O; Postow M; Puzanov I; Zarour HM; Caracò C; Testori A
    J Transl Med; 2020 Apr; 18(1):171. PubMed ID: 32299446
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2019.
    Garbe C; Amaral T; Peris K; Hauschild A; Arenberger P; Bastholt L; Bataille V; Del Marmol V; Dréno B; Fargnoli MC; Grob JJ; Höller C; Kaufmann R; Lallas A; Lebbé C; Malvehy J; Middleton M; Moreno-Ramirez D; Pellacani G; Saiag P; Stratigos AJ; Vieira R; Zalaudek I; Eggermont AMM;
    Eur J Cancer; 2020 Feb; 126():159-177. PubMed ID: 31866016
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Rituximab as a therapeutic option for patients with advanced melanoma.
    Winkler JK; Schiller M; Bender C; Enk AH; Hassel JC
    Cancer Immunol Immunother; 2018 Jun; 67(6):917-924. PubMed ID: 29516155
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Radiological manifestations of immune-related adverse effects observed in patients with melanoma undergoing immunotherapy.
    Sidhu P; Menzies AM; Long G; Carlino M; Lorens S; Kapoor R
    J Med Imaging Radiat Oncol; 2017 Dec; 61(6):759-766. PubMed ID: 29024572
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Merkel cell Carcinoma of the Head and Neck: Recommendations for Diagnostics and Treatment.
    Müller-Richter UDA; Gesierich A; Kübler AC; Hartmann S; Brands RC
    Ann Surg Oncol; 2017 Oct; 24(11):3430-3437. PubMed ID: 28762116
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Long-Term Prognostic Analysis after Endoscopic Endonasal Surgery for Olfactory Neuroblastoma: A Retrospective Study of 13 Cases.
    Zhang L; Niu K; Zhu K; Xia C; Yan J; Zhao W; Wei J; Duan M; Zheng G
    PLoS One; 2016; 11(11):e0166046. PubMed ID: 27806104
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Carbidopa-assisted
    Helali M; Addeo P; Heimburger C; Detour J; Goichot B; Bachellier P; Namer IJ; Taïeb D; Imperiale A
    Ann Nucl Med; 2016 Nov; 30(9):659-668. PubMed ID: 27485404
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016.
    Garbe C; Peris K; Hauschild A; Saiag P; Middleton M; Bastholt L; Grob JJ; Malvehy J; Newton-Bishop J; Stratigos AJ; Pehamberger H; Eggermont AM; ; ;
    Eur J Cancer; 2016 Aug; 63():201-17. PubMed ID: 27367293
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Circulating melanoma cells as a potential biomarker to detect metastasis and evaluate prognosis.
    Hida T; Yoneta A; Wakamatsu K; Yanagisawa K; Ishii-Osai Y; Kan Y; Kato J; Yamashita T
    Australas J Dermatol; 2016 May; 57(2):145-9. PubMed ID: 26931184
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Melanoma: diagnosis, staging, and treatment. Consensus group recommendations.
    Berrocal A; Cabañas L; Espinosa E; Fernández-de-Misa R; Martín-Algarra S; Martínez-Cedres JC; Ríos-Buceta L; Rodríguez-Peralto JL
    Adv Ther; 2014 Sep; 31(9):945-60. PubMed ID: 25145549
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. New-onset mediastinal and central nervous system sarcoidosis in a patient with metastatic melanoma undergoing ctla4 monoclonal antibody treatment.
    Murphy KP; Kennedy MP; Barry JE; O'Regan KN; Power DG
    Oncol Res Treat; 2014; 37(6):351-3. PubMed ID: 24903767
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients.
    Kaufman KL; Mactier S; Armstrong NJ; Mallawaaratchy D; Byrne SN; Haydu LE; Jakrot V; Thompson JF; Mann GJ; Scolyer RA; Christopherson RI
    Clin Exp Metastasis; 2014 Apr; 31(4):407-21. PubMed ID: 24435119
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.